2008
DOI: 10.1016/j.pharmthera.2008.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Impaired energetics in heart failure — A new therapeutic target

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 172 publications
0
8
0
Order By: Relevance
“…The marked reduction in ventricular efficiency shown in adult Fontan patients may suggest a novel therapeutic target. A number of agents with the potential to modify myocardial energetics are currently under study in non‐CHD HF and may hold promise in the Fontan population …”
Section: Discussionmentioning
confidence: 99%
“…The marked reduction in ventricular efficiency shown in adult Fontan patients may suggest a novel therapeutic target. A number of agents with the potential to modify myocardial energetics are currently under study in non‐CHD HF and may hold promise in the Fontan population …”
Section: Discussionmentioning
confidence: 99%
“…In the modern era, specific pathophysiological HCM derangements have been targeted in the preclinical realm, and trials are beginning in patients 15,87,88 . Targeting cellular energetic impairment is a promising paradigm in HCM.…”
Section: [H1] Treatment Of Energy Depletionmentioning
confidence: 99%
“…If substrate utilization can be made more efficient and save more energy, then improved contractile reserve results from the same conditions. Various therapeutic agents affect myocardial metabolic pathways 87 A total of 46 patients with symptomatic, nonobstructive HCM were randomly assigned in a double-blind manner to perhexiline (a metabolic modulator or placebo 89 .…”
Section: [H1] Treatment Of Energy Depletionmentioning
confidence: 99%
“…The capacity of the hypertrophied cell to use oxygen has reportedly been further reduced by a high ratio of contractile protein:mitochondria, and mitochondrial function itself may be compromised ( 18 ) . Consequently, an intervention that reduces myocardial oxygen consumption (MVO 2 ) without detriment to myocardial work output could improve cardiac function in hypertrophy and retard the progression to failure ( 19 ) .…”
mentioning
confidence: 99%